“…The present results do not indicate a direct correlation with the cancer cell cytotoxicity of the two derivatives, which are of two orders of magnitude different against most of the investigated cell lines. The anticancer potential of chalcones is correlated with their ability to act on various molecular targets such as ABCG2, tubulin, activated nuclear B cell growth (NF-κB), vascular endothelial growth factor (VEGF), tyrosine kinase receptor (EGFR), mesenchymal-epithelial transition factor (MET), 5-α reductase, ACP-reductase, histone deacetylase, p53, CDC25B (protein tyrosine phosphatase), retinoic acid receptors, estrogenic topoisomerase receptors and MDM2 [9]. Considering the present and our previous results [10][11][12][13][14][15][16], it is reasonable to suppose that the molecular basis of the different biological effects of IIb and IIc is related to the non-covalent interactions of the compounds [49].…”